Mutations in PTCH or SMO are also prevalent in basal cell carcinomas, medulloblastomas, and cancers of the esophagus and bladder (102), and sustained and activated Hh-Gli signaling has led to the development of medulloblastomas in PTCH heterozygous mice (106). The gene discussed is GLI1; the disease is basal cell carcinoma.